Physician profile
Omar A Ibrahimi
NPI 1508061128
$49,645.11
in general payments reported to CMS, 2019-2025
15 companies · $1,343 in 2025
The $1,343 reported for 2025 was more than what 80% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $1,818 · 2021: $22K · 2022: $14K · 2023: $7,968 · 2024: $1,952 · 2025: $1,343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,910 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,542 · Food and Beverage: $1,811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,909.78 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,541.80 |
| Food and Beverage | $1,811.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $38,279.11 | 2019-2023 | |
| Abbvie INC. | $10,366.13 | 2023-2025 | |
| Revance Therapeutics, INC. | $320.29 | 2024 | Daxxify |
| Dermira, INC. | $150.16 | 2019 | |
| Janssen Biotech, INC. | $146.91 | 2024 | Tremfya |
| Strata Skin Sciences, INC. | $68.11 | 2019-2024 | Xtrac |
| Merz North America, INC. | $59.15 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $51.81 | 2023 | |
| Solta Medical, A Division of Bausch Health US, LLC | $43.26 | 2024-2025 | Fraxel |
| Covidien LP | $39.60 | 2019 | |
| Ucb, INC. | $28.96 | 2025 | Bimzelx |
| Genzyme Corporation | $27.39 | 2024 | |
| Incyte Corporation | $25.77 | 2025 | Opzelura |
| Pfizer INC. | $22.58 | 2022 | |
| Galderma Laboratories, L.P. | $15.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Ibrahimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.